- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02735811
OBSERVational Registry on Long-term Outcome of ICD Patients (OBSERVO)
April 12, 2016 updated by: Pietro Palmisano, Azienda Ospedaliera Cardinale G. Panico
The Italian Multicentric OBSERVational Registry on Long-term Outcome of ICD Patients (OBSERVO-ICD Registry)
Multicentric, observational, retrospective registry including patients underwent ICD implantation for any indication.
The primary aim of the registry is to evaluate the long-term outcome of patients receiving an ICD.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Multicentric, observational, retrospective registry including patients underwent ICD implantation for any indication in the period from 2010 to 2012.
The aims of the registry are to evaluate the occurrence of complications related to ICD implantation (including ICD shocks and electrical storm), and the mortality during a long-term follow-up.
Study Type
Observational
Enrollment (Anticipated)
1300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ancona, Italy
- Recruiting
- University Hospital "Umberto I - Lancisi - Salesi"
-
Bologna, Italy, 40138
- Recruiting
- Policlinico S.Orsola-Malpighi
-
Catanzaro, Italy, 88100
- Recruiting
- AO Pugliese-Ciaccio
-
Novara, Italy
- Recruiting
- Ospedale Maggiore della Carita
-
Roma, Italy, 00135
- Recruiting
- Ospedale San Filippo Neri
-
Contact:
- Stefano Aquilani, MD
- Phone Number: +393479657114
- Email: saquilani@yahoo.it
-
-
Lecce
-
Tricase, Lecce, Italy, 73039
- Recruiting
- "Card. G. Panico" Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Consecutive patients underwent ICD implantation from January 2010 to December 2012 for any indication at enrolling hospitals
Description
Inclusion Criteria:
- ICD implantation fo any indication;
- age >18 years
Exclusion Criteria:
- life expectancy of less than one year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Death for any cause
Time Frame: an average of 2 years
|
an average of 2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Complications related to ICD implantation
Time Frame: an average of 2 years
|
an average of 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Pietro Palmisano, MD, Cardiology Unit - "Card. G. Panico" Hospital - Tricase
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2015
Primary Completion (ANTICIPATED)
May 1, 2016
Study Completion (ANTICIPATED)
May 1, 2016
Study Registration Dates
First Submitted
April 2, 2016
First Submitted That Met QC Criteria
April 12, 2016
First Posted (ESTIMATE)
April 13, 2016
Study Record Updates
Last Update Posted (ESTIMATE)
April 13, 2016
Last Update Submitted That Met QC Criteria
April 12, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OBSERVO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiomyopathies
-
St. Jude Children's Research HospitalActive, not recruitingChildhood Cancer | Cardiomyopathy, PrimaryUnited States
-
Yale UniversityPfizerCompletedCardiomyopathies, PrimaryUnited States
-
Nantes University HospitalUniversity Hospital, Angers; University Hospital, Brest; University Hospital,...Recruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingCardiomyopathy | Hypertrophic Cardiomyopathies
-
Tanta UniversityDelta University for Science and TechnologyNot yet recruiting
-
Shandong Suncadia Medicine Co., Ltd.Recruiting
-
Shandong Suncadia Medicine Co., Ltd.Completed
-
Oregon Health and Science UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
University of VirginiaGE HealthcareNot yet recruiting
Clinical Trials on Assesment of long-term outcome of ICD patients
-
Azienda Ospedaliera Cardinale G. PanicoUnknownHeart Failure With Reduced Ejection Fraction | Defibrillators, Implantable | Arrythmia | PacemakerItaly
-
Hospices Civils de LyonCompletedCerebellar HypoplasiaFrance
-
Helixmith Co., Ltd.CompletedDiabetic Neuropathy, Painful | Painful Diabetic NeuropathyUnited States
-
University Hospital, Basel, SwitzerlandCompleted
-
Beam Therapeutics Inc.RecruitingSickle Cell Disease | HemoglobinopathyUnited States
-
Hospices Civils de LyonRecruitingCancer | SarcopeniaFrance
-
Blue Note TherapeuticsEnrolling by invitation
-
City of Hope Medical CenterActive, not recruiting
-
Hospices Civils de LyonCompleted
-
Columbia UniversityCenters for Disease Control and Prevention; Ministry of Health, RwandaCompleted